Science Current Events | Science News | Brightsurf.com
 

Cervical Cancer Current Events | Cervical Cancer News | 9

Sort By: Page Views | Date

Family history of breast cancer does not increase risk of womb cancer
A family history of breast cancer does not increase a woman`s chances of developing womb cancer, finds a 20-year study in the Journal of Medical Genetics. Cancers of the lining of the womb (endometrium) and breast share some of the same reproductive, hormonal, and lifestyle risk factors. The evidence for a genetic link between the two types of... view more... (2002-11-01)

Breast cancer drug receives FDA approval
A new use for the breast cancer drug Herceptin was approved by the FDA yesterday, a move that means more treatment options for the 25 percent of breast cancer patients with early-stage HER-2 positive breast cancer.   view more (2006-11-20)

Chemotherapy and tamoxifen reduce risk of second breast cancer
Among breast cancer patients, both chemotherapy and tamoxifen independently reduced the risk of developing a second cancer in the other breast, according to a study published online December 25 in the Journal of the National Cancer Institute. The risk reduction persisted for at least 10 and 5 years, respectively.   view more (2007-12-26)

Novel lipoplex nanoparticle to be used in 1st human trial treating advanced solid cancer
The first clinical trial of a biologic nanoparticle designed to give back to cancer patients the tumor-busting gene they have lost is expected to start in September at Georgetown University Medical Center.   view more (2005-08-25)

Sexual problems of long-term cancer survivors merit more attention
The first study to look at sexual function in very long-term female survivors of genital-tract cancer found that these women were pleased with the quality of their cancer care but less satisfied with the emotional support and information they received about dealing with the effects of the disease and treatment on sexuality.   view more (2007-07-27)

Tumor painting revolutionizes fight against cancer
A tumor paint developed by researchers at Seattle Children's Hospital Research Institute and Fred Hutchinson Cancer Research Center will help surgeons see where a tumor begins and ends more precisely by illuminating the cancerous cells.   view more (2007-07-16)

Survival of head and neck cancer patients is greatly affected by coexisting ailments
Current estimates for head and neck cancer survival are largely inaccurate because they widely disregard many of the most common diseases such patients have in addition to their primary cancer, says Jay Piccirillo, M.D., a head and neck specialist at Washington University School of Medicine in St. Louis, the Siteman Cancer Center and Barnes-Jewish... view more... (2008-11-20)

Women smokers have higher risk of lung cancer than men smokers, though lower lung cancer death rate
Women who smoke appear to be more susceptible to lung cancer than men who smoke, though women smokers have a lower rate of lung cancer-related death.   view more (2006-07-12)

Virtual biopsy cuts out need for diagnostic surgery
A non-invasive diagnostic tool to detect surface cancers quickly and painlessly using technology currently employed by gyms to calculate body composition has been developed by a QUT PhD medical physics researcher.   view more (2008-01-18)

Study pries into ovarian cancer's deadly secrets
A new University of Michigan Medical School study sheds light on cell defects that lead to one common type of ovarian cancer and puts forth a promising new mouse model that already is being used for preclinical drug testing.   view more (2007-04-12)

Alternatively spliced tissue factor identified as promising new biomarker for aggressive cancers
A recently discovered form of the protein that triggers blood clotting may play a key role in the molecular mechanisms leading to the growth of certain metastatic cancers, according to new research reported by an international team of scientists.   view more (2009-10-27)

Increased ovarian cancer risk not found in women with breast cancer family history
Women with a strong family history of breast cancer but who don't have breast cancer genetic mutations can now be reassured that they are not at increased risk for ovarian cancer.   view more (2005-09-21)

Study produces conflicting findings on the use of anti-anemia drug in cancer patients
Results from a phase III drug trial indicate that an anti-anemia drug did not significantly decrease the need for blood transfusions in patients not on chemotherapy, and decreased overall patient survival when compared to placebo.   view more (2007-04-17)

Women without regular medical care at increased risk of ovarian cancer
In North America, ovarian cancer is the second most common gynecological cancer and is the leading cause of death among women with gynecological cancer. The high mortality is in part due to the difficulty of detecting and diagnosing this condition at an early stage.   view more (2007-03-27)

Breast asymmetry predicts breast cancer
Women who go on to develop breast cancer tend to have breasts that are less symmetrical than women who don't develop the cancer.   view more (2006-03-20)

Warts vaccine -- 1 of many in pipeline
A clinical trial treating the papillomaviruses responsible for genital warts was on target at the halfway mark, according to Australian of the Year 2006 Professor Ian Frazer and trial manager, sexual health specialist Dr David Jardine.   view more (2007-05-10)

Chemistry & Industry Magazine - cover date 6 October 2003
NEWS   view more (2003-10-01)

Healthy bones program reduces hip fractures by 37 percent
Proactive measures can reduce hip fracture rates by an average of 37.2 percent -- and as much as 50 percent -- among those at risk, according to a study conducted by Kaiser Permanente Southern California. The study was published online on November 3 by The Journal of Bone & Joint Surgery, a peer-reviewed journal.   view more (2008-11-05)

Increased levels of Muellerian-inhibiting substance could mean greater breast cancer risk
Women with increased levels of Müllerian inhibiting substance (MIS), best known for regulating in utero sexual differentiation in boys, may be at a greater risk for breast cancer.   view more (2009-10-12)

Media Registration: Europe`s largest breast cancer conference to be held in Barcelona
3rd European Breast Cancer Conference (EBCC-3) Palau de Congressos de Catalunya, Barcelona, Spain 19-23 March 2002 ABOUT EBCC-3"¦ * More than 3000 clinicians, scientists and patient advocates will attend. * Presentations will review new developments in molecular biology, epidemiology, prevention, diagnosis, treatment, psycho-social... view more... (2001-12-04)
Sort By: Page Views | Date
© 2009 BrightSurf.com